Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients

Clinical trial NCT05013034 · UNKNOWN

Trial details

NCT number: NCT05013034
Sponsor: Fort Worth Clinical Sciences Working Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

SARS-CoV-2 Acute Respiratory Disease SARS-CoV2 Infection Cytokine Storm

Start date: 2021-10-15
Primary completion: 2022-10-15
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.